Paper40106110
Left Hepatectomy Enlarged to Segment 1 with Total Vascular Exclusion of the Liver Preserving the Caval Flow with Temporary Portacaval Shunt and Hypothermic Oxygenated Portal Perfusion on Machine for Metastatic Recurrence of a Pleural Chondrosarcoma.
Tribolet A and 3 others. Ann Surg Oncol, 2025. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Left Hepatectomy Enlarged to Segment 1 with Total Vascular Exclusion of the Liver Preserving the Caval Flow with Temporary Portacaval Shunt and Hypothermic Oxygenated Portal Perfusion on Machine for Metastatic Recurrence of a Pleural Chondrosarcoma. Papers, record 40106110. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40106110
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Left Hepatectomy Enlarged to Segment 1 with Total Vascular Exclusion of the Liver Preserving the Caval Flow with Temporary Portacaval Shunt and Hypothermic Oxygenated Portal Perfusion on Machine for Metastatic Recurrence of a Pleural Chondrosarcoma.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepatectomy | Major topic |
| Pleural Neoplasms | Major topic |
| Hypothermia, Induced | Major topic |
| Vena Cava, Inferior | Major topic |
| Neoplasm Recurrence, Local | Major topic |
| Chondrosarcoma | Major topic |
| Portacaval Shunt, Surgical | Major topic |
| Liver Neoplasms | Major topic |
| Humans | |
| Female | |
| Middle Aged | |
| Prognosis | |
| Perfusion | |
| Hepatic Veins |
Source PubMed
References8
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4414545 | Major hepatic resection using vascular isolation and hypothermic perfusion. | Ann Surg | 1974 | https://conductscience.org/library/papers/4414545 | PubMed |
| 2 | 15650638 | In situ hypothermic perfusion of the liver versus standard total vascular exclusion for complex liver resection. | Ann Surg | 2005 | https://conductscience.org/library/papers/15650638 | PubMed |
| 3 | 25019076 | Liver resection using total vascular exclusion of the liver preserving the caval flow, in situ hypothermic portal perfusion and temporary porta-caval shunt: a new technique for central tumors. | Hepatobiliary Surg Nutr | 2014 | https://conductscience.org/library/papers/25019076 | PubMed |
| 4 | 38592622 | Complex Hepatectomy Under Total Vascular Exclusion of the Liver Preserving the Caval Flow with Portal Hypothermic Perfusion and Temporary Portacaval Shunt: A Proof of Concept. | Ann Surg Oncol | 2024 | https://conductscience.org/library/papers/38592622 | PubMed |
| 5 | 34334635 | Hypothermic Oxygenated Machine Perfusion Reduces Early Allograft Injury and Improves Post-transplant Outcomes in Extended Criteria Donation Liver Transplantation From Donation After Brain Death: Results From a Multicenter Randomized Controlled Trial (HOPE ECD-DBD). | Ann Surg | 2021 | https://conductscience.org/library/papers/34334635 | PubMed |
| 6 | 34291769 | Ex Vivo Liver Splitting and Hypothermic Oxygenated Machine Perfusion: Technical Refinements of a Promising Preservation Strategy in Split Liver Transplantation. | Transplantation | 2021 | https://conductscience.org/library/papers/34291769 | PubMed |
| 7 | 35582790 | Liver transplantation of partial grafts after ex situ splitting during hypothermic oxygenated perfusion-The HOPE-Split pilot study. | Liver Transpl | 2022 | https://conductscience.org/library/papers/35582790 | PubMed |
| 8 | 33824957 | Ante situm liver surgery using machine perfusion liver preservation: pilot human experience. | Br J Surg | 2021 | https://conductscience.org/library/papers/33824957 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41148465 | Two-Stage Hepatectomy for Cholangiocarcinoma Under Total Vascular Exclusion with Veno-venous ECMO Bypass and Controlled Closed-loop In Situ Hypothermic Oxygenated Perfusion of the Liver: The Hannover CLIP-Concept. | Ann Surg Oncol | 2026 | https://conductscience.org/library/papers/41148465 | PubMed |
| 41104225 | Hypothermic oxygenated machine perfusion for ante-situm liver resection: a note of caution? | Hepatobiliary Surg Nutr | 2025 | https://conductscience.org/library/papers/41104225 | PubMed |
| 40762430 | Hypothermic Oxygenated Machine Perfusion (HOPE) During Total Vascular Exclusion With Veno-Venous Bypass for Giant Hepatic Hemangioma Resection. | Artif Organs | 2025 | https://conductscience.org/library/papers/40762430 | PubMed |
| 40529927 | In situ liver resection under venovenous bypass (LR-VVB) or venoarterial bypass (LR-VAB) adjunct to total vascular exclusion (TVE) as extreme liver surgery. | Hepatobiliary Surg Nutr | 2025 | https://conductscience.org/library/papers/40529927 | PubMed |
| 40358782 | ASO Author Reflections: Could the Use of a Hypothermic Oxygenated Machine Perfusion Improve Postoperative Outcome After In Situ Hypothermic, Ante Situm, and Ex Situ Liver Resection? | Ann Surg Oncol | 2025 | https://conductscience.org/library/papers/40358782 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40106110
GET https://conductscience.org/api/papers/v1/40106110/authors